The consensus discussion focused on specific genes comprising the breast and ovarian cancer susceptibility genes listed on the National Genomic Test Directory inherited ovarian cancer (R207 V.4.0) and inherited breast cancer and ovarian cancer (R208 V.2.5) panels at the time of the meeting (BRCA1, BRCA2, PALB2, CHEK2, ATM, RAD51C, RAD51D, BRIP1, MLH1, MSH2, MSH6 and PMS2). This evidence concerns the gene MSH2 and ovarian carcinoma.